EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Eosinophils, Eosinophilic Gastrointestinal Diseases, and Inflammatory Bowel Disease: A Critical Review

Giulia Migliorisi, Elisabetta Mastrorocco, Arianna Dal Buono iD, Roberto Gabbiadini, Gaia Pellegatta, Paola Spaggiari, Francesca Racca iD, Enrico Heffler iD, Edoardo Vincenzo Savarino iD, Cristina Bezzio iD, Alessandro Repici, Alessandro Armuzzi iD

Journal of Clinical Medicine · 14.07.2024 · 13 (14) · 4119

DOI: 10.3390/jcm13144119 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 14.07.2024. Verfasst von Giulia Migliorisi und 11 weiteren Autor:innen. Beteiligte Einrichtung: IBD Center, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089 Rozzano, Italy. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Inflammatory bowel disease (IBD) and eosinophilic gastrointestinal diseases (EGIDs) are complex, multifactorial chronic inflammatory disorders affecting the gastrointestinal tract. Their epidemiology, particularly for eosinophilic esophagitis (EoE), is increasing worldwide, with a rise in the co-diagnosis of IBD and EGIDs. Both disorders share common risk factors, such as early exposure to antibiotics or specific dietary habits. Moreover, from a molecular perspective, eosinophilic infiltration is crucial in the diagnosis of eosinophilic disorders, and it also plays a pivotal role in IBD histological diagnosis. Indeed, recent evidence highlights the significant role of eosinophils in the health of the intestinal mucosal barrier and as mediators between innate and acquired immunity, even indicating a potential role in IBD pathogenesis. This narrative review aims to summarize the current evidence regarding the common clinical and molecular aspects of EGIDs and IBD and the current state of knowledge regarding overlap conditions and their pathogenesis.

Methods

Pubmed was searched until May 2023 to assess relevant studies describing the epidemiology, pathophysiology, and therapy of EGIDs in IBD.

Results

The immune pathways and mechanisms underlying both EGIDs and IBD remain partially known. An improved understanding of the role of eosinophils in overlapping conditions could lead to enhanced diagnostic precision, the development of more effective future therapeutic strategies, and a more accurate prediction of patient response. Consequently, the identification of red flags indicative of an eosinophilic disorder in IBD patients is of paramount importance and must be evaluated on a case-by-case basis.

Schlagwörter

Stichwörter der Autor:innen

eosinophilic esophagitiseosinophilic gastrointestinal diseaseeosinophilsinflammatory bowel disease

Autor:innen und Institutionen

  • IBD Center, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089 Rozzano, Italy.
  • Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072 Pieve Emanuele, Italy.
  • Endoscopic Unit, Department of Gastroenterology, IRCCS Humanitas Research Hospital, 20089 Rozzano, Italy.
  • Department of Pathology, Humanitas Research Hospital, 20089 Rozzano, Italy.
  • Personalized Medicine, Asthma and Allergy, IRCCS-Humanitas Research Hospital, 20089 Rozzano, Italy.
  • Department of Surgery, Oncology and Gastroenterology, Department of Medical and Surgical Specialties, University of Padua, 35122 Padova, Italy.

ORCID-Profile: Arianna Dal Buono, Francesca Racca, Enrico Heffler, Edoardo Vincenzo Savarino, Cristina Bezzio, Alessandro Armuzzi

Zitieren

APA

Migliorisi, G., Mastrorocco, E., Dal Buono, A., Gabbiadini, R., Pellegatta, G., Spaggiari, P., Racca, F., Heffler, E., Savarino, E. V., Bezzio, C., Repici, A., & Armuzzi, A. (2024). Eosinophils, Eosinophilic Gastrointestinal Diseases, and Inflammatory Bowel Disease: A Critical Review. Journal of Clinical Medicine, 13(14), 4119. https://doi.org/10.3390/jcm13144119

Vancouver

Migliorisi G, Mastrorocco E, Dal Buono A, Gabbiadini R, Pellegatta G, Spaggiari P, et al. Eosinophils, Eosinophilic Gastrointestinal Diseases, and Inflammatory Bowel Disease: A Critical Review. Journal of Clinical Medicine. 2024;13(14):4119. doi:10.3390/jcm13144119

BibTeX
@article{Migliorisi2024,
  author = {Migliorisi, Giulia and Mastrorocco, Elisabetta and Dal Buono, Arianna and Gabbiadini, Roberto and Pellegatta, Gaia and Spaggiari, Paola and Racca, Francesca and Heffler, Enrico and Savarino, Edoardo Vincenzo and Bezzio, Cristina and Repici, Alessandro and Armuzzi, Alessandro},
  title = {Eosinophils, Eosinophilic Gastrointestinal Diseases, and Inflammatory Bowel Disease: A Critical Review},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {13},
  number = {14},
  pages = {4119},
  doi = {10.3390/jcm13144119}
}
Kostenlos starten →